6 patents
Utility
CRYSTALLINE SUCCINATE SALT OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[1,2-a]PYRAZIN-8-AMINE
25 May 23
Peter A. Blomgren, Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Jennifer R. Lo, Scott A. Mitchell, Aaron C. Schmitt, Jin-Ming Xiong, Jianjun Xu, Sundaramoorthi Swaminathan, Zhongdong Zhao
Filed: 18 Nov 22
Utility
CRYSTALLINE FORMS OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[l,2-a]PYRAZIN-8-AMINE AS SYK INHIBITORS
30 Mar 23
Patricia Andres, Peter C. Fung, Pierre Giguere, Chiajen Lai, Craig Stewart, Jing Teng, Duong D. Tran, Iva Trantcheva, Yarmuch
Filed: 19 May 22
Utility
Hydrates of Polymorphs of 6-(1H-INDAZOL-6-YL)-N-(4-MORPHOLINOPHENYL)-2,3-DIHYDROIMIDAZO[1,2-A]PYRAZIN-8-AMINE Bis-mesylate As Syk Inhibitors
25 Aug 22
Tim G. Elford, Peter Chee-Chu Fung, Paul Robert Hartmeier, Jesper Alexis Jernelius, Henry Morrison
Filed: 4 May 22
Utility
Compounds, Compositions, and Methods for Modulating CDK9 Activity
6 Jan 22
Peter MIKOCHIK, Joseph VACCA, David FREEMAN, Andrew S. TASKER
Filed: 15 Sep 21
Utility
CRYSTALLINE MONOMESYLATE SALT OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[1,2-a]PYRAZIN-8-AMINE
4 Mar 21
Peter A. Blomgren, Kevin S. Currie, Jeffrey E. Kropf, Seung H. Lee, Jennifer R. Lo, Scott A. Mitchell, Aaron C. Schmitt, Sundaramoorthi Swaminathan, Jin-Ming Xiong, Jianjun Xu, Zhongdong Zhao
Filed: 28 Oct 20
Utility
Compounds, Compositions, and Methods for Modulating CDK9 Activity
29 Apr 20
Peter MIKOCHIK, Joseph VACCA, David FREEMAN, Andrew S. TASKER
Filed: 28 Oct 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first